The Scientist caught up with cardiac stem cell researcher Mark Sussman to get his thoughts on the American Heart Association’s Scientific Sessions meeting.
As researchers conduct the most rigorous human trials of cardiac cell therapies yet attempted, a clear picture of whether these treatments actually work is imminent.
A handful of stem cell therapeutics for vision disorders are showing promise in early-stage trials, and still more are in development. But there’s a long road to travel before patients see real benefit.